Cell Discovery (Apr 2024)
Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue
- Jiaying Wu,
- Tuo Li,
- Meng Guo,
- Junsong Ji,
- Xiaoxi Meng,
- Tianlong Fu,
- Tengfei Nie,
- Tongkun Wei,
- Ying Zhou,
- Weihua Dong,
- Ming Zhang,
- Yongquan Shi,
- Xin Cheng,
- Hao Yin,
- Clinical Group
Affiliations
- Jiaying Wu
- Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science
- Tuo Li
- Department of Endocrinology, Shanghai Changzheng Hospital (Second Affiliated Hospital of Naval Medical University)
- Meng Guo
- National Key Laboratory of Medical Immunology & Institute of Immunology, Naval Medical University
- Junsong Ji
- Organ Transplant Center, Shanghai Changzheng Hospital
- Xiaoxi Meng
- Department of Interventional Radiology, Shanghai Changzheng Hospital
- Tianlong Fu
- Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science
- Tengfei Nie
- Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science
- Tongkun Wei
- Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science
- Ying Zhou
- Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science
- Weihua Dong
- Department of Interventional Radiology, Shanghai Changzheng Hospital
- Ming Zhang
- Department of Urology, Renji Hospital, School of Medicine
- Yongquan Shi
- Department of Endocrinology, Shanghai Changzheng Hospital (Second Affiliated Hospital of Naval Medical University)
- Xin Cheng
- Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science
- Hao Yin
- Organ Transplant Center, Shanghai Changzheng Hospital
- Clinical Group
- DOI
- https://doi.org/10.1038/s41421-024-00662-3
- Journal volume & issue
-
Vol. 10,
no. 1
pp. 1 – 5
Abstract
No abstracts available.